on last low.
TA aside, Rite Aid is still a big player in health care that was beaten down after multiple failed buyouts.
The stock is undervalued.
Careful of the Reverse stock split the board has approved. No official date of execution yet, but I believe we see growth regardless.
The stock being undervalued, TA looking like a bottom is in, and/or the possibility of being bought out anytime makes the risk/reward on Rite Aid well worth over the next few months.